A detailed history of Great West Life Assurance CO transactions in Pfizer Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 6,800,748 shares of PFE stock, worth $190 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
6,800,748
Previous 6,621,189 2.71%
Holding current value
$190 Million
Previous $190 Million 0.39%
% of portfolio
0.38%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $4.65 Million - $5.34 Million
179,559 Added 2.71%
6,800,748 $189 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $4.47 Million - $5.81 Million
171,142 Added 2.65%
6,621,189 $190 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $7.08 Million - $8.28 Million
220,728 Added 3.54%
6,450,047 $214 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $16.3 Million - $18.9 Million
451,990 Added 7.82%
6,229,319 $230 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $423,875 - $551,824
10,761 Added 0.19%
5,777,329 $236 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $3.36 Million - $4.39 Million
80,595 Added 1.42%
5,766,568 $297 Million
Q3 2022

Nov 01, 2022

SELL
$43.76 - $53.42 $3.24 Million - $3.96 Million
-74,103 Reduced 1.29%
5,685,973 $249 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $268 Million - $318 Million
5,760,076 New
5,760,076 $303 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $298 Million - $353 Million
-6,402,983 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $11.2 Million - $13.9 Million
-245,431 Reduced 3.69%
6,402,983 $348 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $19 Million - $28.1 Million
459,490 Added 7.42%
6,648,414 $391 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $10.5 Million - $13.5 Million
-267,544 Reduced 4.14%
6,188,924 $268 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $10.1 Million - $11.4 Million
281,080 Added 4.55%
6,456,468 $253 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $2.35 Million - $2.65 Million
-70,145 Reduced 1.12%
6,175,388 $222 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $11.5 Million - $14.7 Million
344,231 Added 5.83%
6,245,533 $229 Million
Q3 2020

Nov 17, 2020

SELL
$31.75 - $37.25 $3.23 Million - $3.79 Million
-101,844 Reduced 1.7%
5,901,302 $205 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $1.8 Million - $2.12 Million
56,779 Added 0.95%
6,003,146 $209 Million
Q2 2020

Aug 17, 2020

BUY
$30.12 - $36.54 $2.23 Million - $2.7 Million
73,881 Added 1.26%
5,946,367 $194 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $20,759 - $29,660
-768 Reduced 0.01%
5,872,486 $193 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $25.3 Million - $28.8 Million
-769,895 Reduced 11.59%
5,873,254 $218 Million
Q3 2019

Oct 25, 2019

BUY
$32.49 - $42.13 $1.24 Million - $1.61 Million
38,286 Added 0.58%
6,643,149 $239 Million
Q2 2019

Jul 31, 2019

SELL
$36.98 - $41.52 $6.92 Million - $7.77 Million
-187,153 Reduced 2.76%
6,604,863 $0
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $13.6 Million - $14.9 Million
362,522 Added 5.64%
6,792,016 $288 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $58.3 Million - $66.5 Million
-1,516,157 Reduced 19.08%
6,429,494 $271 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $26.7 Million - $32.3 Million
-773,694 Reduced 8.87%
7,945,651 $351 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $13.3 Million - $14.2 Million
403,854 Added 4.86%
8,719,345 $317 Million
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $23.2 Million - $26.9 Million
725,799 Added 9.56%
8,315,491 $295 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $6.42 Million - $6.81 Million
192,899 Added 2.61%
7,589,692 $275 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $229 Million - $253 Million
7,396,793
7,396,793 $263 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.